CN215841160U - Postpartum uterine cavity drug administration device - Google Patents
Postpartum uterine cavity drug administration device Download PDFInfo
- Publication number
- CN215841160U CN215841160U CN202121367902.0U CN202121367902U CN215841160U CN 215841160 U CN215841160 U CN 215841160U CN 202121367902 U CN202121367902 U CN 202121367902U CN 215841160 U CN215841160 U CN 215841160U
- Authority
- CN
- China
- Prior art keywords
- syringe
- uterine cavity
- silica gel
- tube body
- liquid medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000001647 drug administration Methods 0.000 title description 2
- 239000003814 drug Substances 0.000 claims abstract description 79
- 238000002347 injection Methods 0.000 claims abstract description 36
- 239000007924 injection Substances 0.000 claims abstract description 36
- 238000012377 drug delivery Methods 0.000 claims abstract description 16
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 38
- 239000000741 silica gel Substances 0.000 claims description 38
- 229910002027 silica gel Inorganic materials 0.000 claims description 38
- 239000007788 liquid Substances 0.000 abstract description 52
- 230000003252 repetitive effect Effects 0.000 abstract description 3
- 239000002699 waste material Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- 230000005484 gravity Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 4
- 238000005086 pumping Methods 0.000 description 4
- 210000004291 uterus Anatomy 0.000 description 4
- 229940079593 drug Drugs 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000004996 female reproductive system Anatomy 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000009027 insemination Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
Images
Landscapes
- Surgical Instruments (AREA)
Abstract
The utility model discloses a postpartum uterine cavity drug delivery device, which belongs to the technical field of drug delivery devices and comprises a tube body, wherein a fixing ball is sleeved on the tube body, the inner wall of the fixing ball is fixedly connected with the tube body, a limiting device and an injection device are arranged on the tube body, and the injection device is positioned on the right side of the limiting device. The utility model discloses a, the user of service inserts the body right-hand member after taking out full liquid medicine with injection apparatus inside, then the user of service promotes injection apparatus, injection apparatus pushes inside its inside liquid medicine into the body, the liquid medicine gets into patient palace intracavity portion along the inside of body, user of service operates injection apparatus, make the inside remaining liquid medicine of body then by gaseous promotion to the inside removal of patient palace intracavity portion, user of service repetitive operation injection apparatus until the inside liquid medicine of body get into completely palace chamber can, injection apparatus's setting can avoid the liquid medicine extravagant, the problem of rocking when having solved the device of feeding medicine in the past postpartum palace chamber and having the wasting of resources and dosing.
Description
Technical Field
The utility model relates to the technical field of drug delivery devices, in particular to a postpartum uterine cavity drug delivery device.
Background
The uterine cavity is the space of the uterus, also called as the uterus, the uterus is a single muscular organ, mainly comprises smooth muscle, the wall thickness cavity is small, is rich in expansibility, the shape, the size, the position and the structure of the uterus vary with different ages, and are changed by the influence of menstrual cycle and pregnancy, because the structure of female genitals is special, the diseases in the uterine cavity of the female reproductive system, such as cervicitis, cervical erosion and the like, are common diseases in clinic, the treatment mostly adopts a mode of directly administering medicine to a lesion part, and the existing uterine cavity administration devices adopt artificial insemination tubes or embryo transplantation tubes.
When the device is used clinically, the existing uterine cavity drug delivery device can not adapt to the sizes of the vaginal mouths or the depths of the vaginas of different users correspondingly, a vaginal dilator or a cervical clamp is often used in a cooperative mode, the drugs are easy to flow out of the cervical mouths under the influence of factors such as gravity and the like, and more drugs are remained in the drug delivery device when the device is used, so that the drugs can not effectively act on the pathological change parts, therefore, the professional in the field provides the postpartum uterine cavity drug delivery device, and the problems are solved.
SUMMERY OF THE UTILITY MODEL
Aiming at the problems in the prior art, the utility model aims to provide a postpartum uterine cavity drug delivery device to solve the problems of resource waste and drug delivery shaking of the existing postpartum uterine cavity drug delivery device.
In order to solve the above problems, the present invention adopts the following technical solutions.
The utility model provides a palace chamber device of dosing postpartum, includes the body, the cover is equipped with the fixed ball on the body, fixed connection between the inner wall of fixed ball and the body, be provided with stop device and injection device on the body, injection device is located stop device's right side.
As a further description of the above technical solution: the left side fixedly connected with silica gel head of body, overhead evenly distributed's the play medicine mouth of having seted up of silica gel, it all is linked together with the inside of body to go out the medicine mouth.
As a further description of the above technical solution: stop device includes the silica gel piece, the inner wall sliding connection of silica gel piece is on the body, set up evenly distributed's external screw thread on the body, the right side of silica gel piece is rotated and is connected with the screw ring, through external screw thread threaded connection between screw ring and the body.
As a further description of the above technical solution: the top and the bottom of body have all been seted up the spout, two equal sliding connection in inside of spout has the draw runner, two the equal fixed connection in one side that the draw runner was carried on the back mutually is on the inner wall of silica gel piece.
As a further description of the above technical solution: the injection device comprises an injector, the injector is inserted on the right side of the tube body, the injector is in contact with the inner wall of the tube body, the inner wall of the tube body is hinged with two semicircular plates, the inner wall of the tube body is fixedly connected with two limiting blocks, the two limiting blocks are respectively positioned on the right sides of the two semicircular plates, the top of the tube body is fixedly connected with a one-way valve, the bottom end of the one-way valve penetrates through and extends to the inside of the tube body, and the one-way valve is positioned on one side of the injector opposite to the semicircular plates.
As a further description of the above technical solution: the inner wall of the tube body is fixedly connected with a limiting ring, and the limiting ring is positioned on the left side of the injector.
Compared with the prior art, the utility model has the advantages that:
(1) when the device is needed to be used for feeding medicine to the uterine cavity of a patient, firstly, a user inserts the front end of the tube body into the cervical orifice of the patient, the insertion can be stopped until the fixing ball is attached to the cervical orifice, when the fixing ball is positioned behind the cervical orifice, the user operates the limiting device, the limiting device starts to move leftwards on the tube body, when the limiting device is tightly attached to the private part of the patient, the user can stop the operation, the limiting device can avoid the situation that the tube body shakes in the medicine feeding process due to different vaginal depths of the patient, meanwhile, the situation that the medicine liquid flows out due to gravity after entering the uterine cavity of the patient to cause waste of the medicine liquid can be prevented, when the medicine is needed to be fed into the uterine cavity of the patient, the user inserts the right end of the tube body after the inside of the injection device is fully pumped with the medicine liquid, then the user pushes the injection device, and the medicine liquid in the injection device is pushed into the tube body, inside the liquid medicine got into patient palace chamber along the inside of body, service personnel operated injection device for the inside remaining liquid medicine of body then is promoted to the inside removal of patient palace chamber by gas, and service personnel repetitive operation injection device until the inside liquid medicine of body get into palace chamber completely can, and injection device's setting can avoid the liquid medicine extravagant, has solved in the past postpartum palace chamber and has dosed the problem that the device has the wasting of resources and rocks when dosing.
(2) This scheme, the silica gel head of silica gel material is difficult for causing the secondary damage to patient's health, and evenly distributed's play medicine mouth can make the more even blowout of liquid medicine simultaneously to can play better drug effect.
(3) This scheme, after the fixed ball is located the cervical orifice, the user rotates the screw ring, the screw ring takes place to rotate the back and begins to remove on the body through the external screw thread, thereby make the silica gel piece by screw ring to left promotion, the user can stop rotating the screw ring when silica gel piece and patient's private parts are hugged closely, thereby stop device's setting can avoid patient's vagina degree of depth to differ to lead to appearing rocking in the in-process body of dosing, also can prevent simultaneously that the liquid medicine from receiving the gravity outflow after getting into patient's palace chamber, it is extravagant to cause the liquid medicine.
(4) This scheme, the draw runner also can be at the inside removal of spout when the silica gel piece is removing, and the cooperation between spout and the draw runner is used and can be played the restriction effect to the silica gel piece, avoids the silica gel piece to arouse the patient discomfort along with screw ring synchronous rotation when contacting the patient.
(5) In the scheme, when the medicine needs to be administered to the interior of the uterine cavity of a patient, a user inserts the right end of the tube body after pumping the medicine liquid in the syringe, then the user pushes the syringe, the syringe pushes the medicine liquid in the syringe into the tube body, the semicircular plates are pushed by the pushing force, the medicine liquid enters the interior of the uterine cavity of the patient along the interior of the tube body, the user pulls the piston of the syringe after the medicine liquid in the syringe is completely input, the semicircular plates are reset under the influence of the suction force of the syringe, the residual medicine liquid in the tube body is not influenced by the syringe due to the fact that the two semicircular plates are limited by the limiting block to be closed, air outside the check valve enters the tube body and is sucked by the syringe due to the suction force generated by the syringe, then the user pushes the syringe, the semicircular plates are pushed away by the air, the residual medicine liquid in the tube body is moved to the interior of the uterine cavity of the patient by the air, and the user repeatedly operates the syringe until the medicine liquid in the tube body completely enters the uterine cavity, the injection device can avoid waste of liquid medicine.
(6) This scheme, the setting of spacing ring can play the restriction when inserting the syringe, avoids the user to insert the syringe and leads to injection device unable function deeply.
Drawings
FIG. 1 is a schematic perspective view of the present invention;
FIG. 2 is a schematic front sectional view of the present invention;
FIG. 3 is an enlarged schematic view of the structure at A in FIG. 2 according to the present invention;
FIG. 4 is a schematic perspective view of the spacing device of the present invention;
fig. 5 is a schematic perspective view of a silica gel head according to the present invention.
The reference numbers in the figures illustrate:
1. a pipe body; 2. fixing the ball; 3. a limiting device; 301. a silica gel block; 302. an external thread; 303. a threaded ring; 4. an injection device; 401. an injector; 402. a semicircular plate; 403. a limiting block; 404. a one-way valve; 5. a silica gel head; 6. a medicine outlet; 7. a chute; 8. a slide bar; 9. a limit ring.
Detailed Description
The technical solution in the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings in the embodiments of the present invention;
referring to fig. 1 to 5, the postpartum uterine cavity drug delivery device of the present invention includes a tube body 1, a fixing ball 2 is sleeved on the tube body 1, an inner wall of the fixing ball 2 is fixedly connected with the tube body 1, a limiting device 3 and an injection device 4 are disposed on the tube body 1, and the injection device 4 is located on a right side of the limiting device 3.
In the utility model, when the device is needed to be used for feeding medicine to the uterine cavity of a patient, firstly, a user inserts the front end of the tube body 1 into the cervical orifice of the patient, the insertion can be stopped until the fixing ball 2 is attached to the cervical orifice, when the fixing ball 2 is positioned at the cervical orifice, the user operates the limiting device 3, the limiting device 3 starts to move leftwards on the tube body 1, when the limiting device 3 is tightly attached to the private part of the patient, the user can stop the operation, the limiting device 3 can avoid the shaking of the tube body 1 in the medicine feeding process due to the different vaginal depths of the patient, and can prevent the medicine liquid from flowing out under the gravity after entering the uterine cavity of the patient to cause the waste of the medicine liquid, when the medicine is needed to be fed into the uterine cavity of the patient, the user inserts the right end of the tube body 1 after pumping the medicine liquid into the injection device 4, then pushes the injection device 4, and the injection device 4 pushes the medicine in the tube body 1, the liquid medicine gets into patient's palace intracavity portion along the inner wall of body 1, and user of service operates injection device 4 for the inside remaining liquid medicine of body 1 then is promoted to the inside removal of patient's palace intracavity by gas, and user of service repetitive operation injection device 4 until the inside liquid medicine of body 1 get into the palace chamber completely can, and injection device 4 sets up can avoid the liquid medicine extravagant, has solved in the past postpartum palace chamber device of dosing and has had the wasting of resources and the problem of rocking when dosing.
Please refer to fig. 1, 2 and 5, wherein: the left side fixedly connected with silica gel head 5 of body 1, set up evenly distributed's play medicine mouth 6 on the silica gel head 5, go out medicine mouth 6 and all be linked together with the inside of body 1.
In the utility model, the silica gel heads 5 made of silica gel are not easy to cause secondary damage to the body of a patient, and meanwhile, the uniformly distributed medicine outlets 6 can enable medicine liquid to be sprayed out more uniformly, so that better medicine effect can be achieved.
Please refer to fig. 1, 2 and 4, wherein: stop device 3 includes silica gel block 301, and silica gel block 301's inner wall sliding connection sets up evenly distributed's external screw thread 302 on body 1, and silica gel block 301's right side is rotated and is connected with threaded ring 303, through external screw thread 302 threaded connection between threaded ring 303 and the body 1.
In the utility model, when the fixing ball 2 is positioned at the cervical orifice, a user rotates the threaded ring 303, the threaded ring 303 starts to move on the tube body 1 through the external thread 302 after rotating, so that the silica gel block 301 is pushed leftwards by the threaded ring 303, the user can stop rotating the threaded ring 303 when the silica gel block 301 is tightly attached to the private part of a patient, the arrangement of the limiting device 3 can avoid the phenomenon that the tube body 1 shakes in the administration process due to different vaginal depths of the patient, and can also prevent liquid medicine from flowing out by gravity after entering the uterine cavity of the patient to cause waste of the liquid medicine.
Please refer to fig. 1 and 2, wherein: spout 7 has all been seted up with the bottom at the top of body 1, and the equal sliding connection in inside of two spout 7 has draw runner 8, and the equal fixed connection in one side that two draw runners 8 carried on the back mutually is on silica gel block 301's inner wall.
In the utility model, when the silica gel block 301 moves, the slide bar 8 also moves in the chute 7, and the cooperation between the chute 7 and the slide bar 8 can limit the silica gel block 301, so that discomfort of a patient caused by the fact that the silica gel block 301 synchronously rotates along with the threaded ring 303 and contacts the patient is avoided.
Please refer to fig. 1-3, wherein: injection device 4 includes syringe 401, syringe 401 is pegged graft on the right side of body 1, syringe 401 contacts with the inner wall of body 1, it has two semicircle boards 402 to articulate on the inner wall of body 1, two restriction blocks 403 of fixedly connected with on the inner wall of body 1, two restriction blocks 403 are located the right side of two semicircle boards 402 respectively, the top fixedly connected with check valve 404 of body 1, the bottom of check valve 404 runs through and extends to the inside of body 1, check valve 404 is located syringe 401 and the relative one side of semicircle board 402.
In the utility model, when the administration is needed to the interior of the uterine cavity of a patient, a user inserts the right end of the tube body 1 after fully pumping the interior of the syringe 401, then pushes the syringe 401, the syringe 401 pushes the interior liquid medicine into the tube body 1, the semicircular plate 402 is pushed by the pushing force, the liquid medicine enters the interior of the uterine cavity of the patient along the interior of the tube body 1, after the liquid medicine in the syringe 401 is completely input, the user pulls the piston of the syringe 401, the semicircular plate 402 is reset under the influence of the suction force of the syringe 401, the two semicircular plates 402 are closed under the restriction of the restriction block 403, so that the liquid medicine remained in the tube body 1 is not influenced by the syringe 401, the air outside the one-way valve 404 enters the tube body 1 and is sucked by the syringe 401, then the user pushes the syringe 401, the semicircular plate 402 is pushed by the air, the liquid medicine remained in the tube body 1 is pushed by the air and moves towards the interior of the uterine cavity of the patient, the user can repeatedly operate the syringe 401 until the liquid medicine in the tube body 1 completely enters the uterine cavity, and the injection device 4 can avoid waste of the liquid medicine.
Please refer to fig. 2 and 3, wherein: the inner wall of the tube body 1 is fixedly connected with a limiting ring 9, and the limiting ring 9 is positioned on the left side of the injector 401.
In the utility model, the limiting ring 9 can play a limiting role when the injector 401 is inserted, so that the situation that the injection device 4 cannot operate due to the fact that a user inserts the injector 401 too deeply is avoided.
The working principle is as follows: when the device is needed to be used for feeding medicine to the uterine cavity of a patient, firstly, a user inserts the front end of the tube body 1 into the cervical orifice of the patient until the fixing ball 2 is attached to the cervical orifice, the insertion can be stopped, when the fixing ball 2 is positioned at the cervical orifice, the user rotates the threaded ring 303, the threaded ring 303 starts to move on the tube body 1 through the external thread 302 after rotating, so that the silica gel block 301 is pushed leftwards by the threaded ring 303, when the silica gel block 301 is tightly attached to the private part of the patient, the user can stop rotating the threaded ring 303, the arrangement of the limiting device 3 can avoid the shaking of the tube body 1 in the medicine feeding process due to different vaginal depths of the patient, and can also prevent the medicine liquid from flowing out due to gravity after entering the uterine cavity of the patient and causing waste of the medicine liquid, when the medicine is needed to be fed into the uterine cavity of the patient, the user inserts the right end of the tube body 1 after pumping the medicine liquid into the syringe 401, then a user pushes the syringe 401, the syringe 401 pushes the internal liquid medicine into the tube body 1, the semicircular plates 402 are pushed by the pushing force, the liquid medicine is sprayed into the uterine cavity of the patient through the medicine outlet 6 on the silica gel head 5 along the inner wall of the tube body 1, when the liquid medicine in the syringe 401 is completely input, the user pulls the piston of the syringe 401, the semicircular plates 402 are reset under the influence of the suction force of the syringe 401, the two semicircular plates 402 are limited by the limiting block 403 to be closed, so that the liquid medicine remained in the tube body 1 is not influenced by the syringe 401, the air outside the one-way valve 404 enters the tube body 1 and is sucked by the syringe 401 through the suction force generated by the syringe 401, then the user pushes the syringe 401, the semicircular plates 402 are pushed away by air, the liquid medicine remained in the tube body 1 enters the uterine cavity of the patient to move, and the user repeatedly operates the syringe 401 until the liquid medicine in the tube body 1 completely enters the uterine cavity, the injection device 4 can avoid the waste of liquid medicine, and solves the problems of resource waste and shaking during administration of the previous postpartum uterine cavity administration device.
The foregoing is only a preferred embodiment of the present invention; the scope of the utility model is not limited thereto. Any person skilled in the art should be able to cover the technical scope of the present invention by equivalent or modified solutions and modifications within the technical scope of the present invention.
Claims (6)
1. The utility model provides a palace chamber device of dosing postpartum, includes body (1), its characterized in that: the injection device is characterized in that a fixing ball (2) is sleeved on the pipe body (1), the inner wall of the fixing ball (2) is fixedly connected with the pipe body (1), a limiting device (3) and an injection device (4) are arranged on the pipe body (1), and the injection device (4) is located on the right side of the limiting device (3).
2. A postpartum uterine cavity drug delivery device according to claim 1, characterized in that: the left side fixedly connected with silica gel head (5) of body (1), set up evenly distributed's play medicine mouth (6) on silica gel head (5), it all is linked together with the inside of body (1) to go out medicine mouth (6).
3. A postpartum uterine cavity drug delivery device according to claim 1, characterized in that: stop device (3) include silica gel block (301), the inner wall sliding connection of silica gel block (301) is on body (1), evenly distributed's external screw thread (302) have been seted up on body (1), the right side of silica gel block (301) is rotated and is connected with screw ring (303), through external screw thread (302) threaded connection between screw ring (303) and body (1).
4. A postpartum uterine cavity drug delivery device according to claim 3, characterized in that: spout (7) have all been seted up with the bottom at the top of body (1), two the equal sliding connection in inside of spout (7) has draw runner (8), two the equal fixed connection in one side that draw runner (8) carried on the back mutually is on the inner wall of silica gel block (301).
5. A postpartum uterine cavity drug delivery device according to claim 1, characterized in that: injection device (4) include syringe (401), syringe (401) are pegged graft on the right side of body (1), syringe (401) contact with the inner wall of body (1), it has two semicircle boards (402) to articulate on the inner wall of body (1), two restriction pieces (403) of fixedly connected with on the inner wall of body (1), two restriction piece (403) are located the right side of two semicircle boards (402) respectively, the top fixedly connected with check valve (404) of body (1), the inside of body (1) is run through and is extended to the bottom of check valve (404), check valve (404) are located syringe (401) and one side that semicircle board (402) is relative.
6. A postpartum uterine cavity drug delivery device according to claim 5, characterized in that: the syringe is characterized in that a limiting ring (9) is fixedly connected to the inner wall of the tube body (1), and the limiting ring (9) is located on the left side of the syringe (401).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202121367902.0U CN215841160U (en) | 2021-06-21 | 2021-06-21 | Postpartum uterine cavity drug administration device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202121367902.0U CN215841160U (en) | 2021-06-21 | 2021-06-21 | Postpartum uterine cavity drug administration device |
Publications (1)
Publication Number | Publication Date |
---|---|
CN215841160U true CN215841160U (en) | 2022-02-18 |
Family
ID=80334290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202121367902.0U Expired - Fee Related CN215841160U (en) | 2021-06-21 | 2021-06-21 | Postpartum uterine cavity drug administration device |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN215841160U (en) |
-
2021
- 2021-06-21 CN CN202121367902.0U patent/CN215841160U/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2513007A1 (en) | Vaginal or rectal applicator | |
CN215841160U (en) | Postpartum uterine cavity drug administration device | |
CN213312841U (en) | Gynecological medicine applicator | |
CN211132669U (en) | Cervical medicine feeder for obstetrics and gynecology department | |
CN112169149A (en) | Noninvasive gynecological nursing medication device | |
CN207980162U (en) | A kind of anorectal surgical drug delivery device | |
CN2785605Y (en) | Block type soaking and cleaning device for vaginal drug administration | |
CN210873672U (en) | Push-rod type vagina medicine feeder for treating gynecological diseases | |
CN201404583Y (en) | Vagina medicine administrating device | |
CN210121289U (en) | Medicine feeder for gynecological nursing | |
CN211050448U (en) | Novel enemator for enterostomy patient | |
CN209827947U (en) | Clinical device of dosing of gynaecology and obstetrics | |
CN210472777U (en) | Vagina drug administration injector | |
CN209286479U (en) | A kind of convenient drug delivery device for gynecopathy therapeutic | |
CN220213438U (en) | Multifunctional medicine feeder for children | |
CN218853318U (en) | Medicine feeder for gynecological nursing | |
CN213667487U (en) | Gynecological drug delivery device | |
CN213100316U (en) | Anus drug administration device | |
CN217745332U (en) | Gynecological medicine applicator | |
CN211675861U (en) | Clinical medicine feeder of gynaecology and obstetrics | |
CN210472781U (en) | Disposable medicine feeder for vagina of young woman | |
CN212067434U (en) | Cervical ware of dosing for gynaecology's treatment | |
CN213077181U (en) | Novel uterine cavity drug delivery device | |
CN204890926U (en) | Multi -functional chamber way ware of dosing | |
CN212914175U (en) | Uterine cavity drug feeder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20220218 |